palivizumab

pharmaceutical drug
rdfs:label
"palivizumab"@en
skos:altLabel
"MEDI-493"@en
"Synagis Abbosynagis"@en
"anti-RSV"@en
schema:description
"pharmaceutical drug"@en
schema:dateModified "2026-11-04T17:28:29+00:00"^^xsd:dateTime
schema:version 2564773559
wikibase:identifiers 19
wikibase:sitelinks 15
wikibase:statements 31
p:P10245 wd:statement/Q412765-6ae3461a-4f59-b6af-1779-aafaea58473c
p:P10283 wd:statement/Q412765-DE988453-A3CB-455A-B37D-6577F9C14DB6
p:P11143 wd:statement/Q412765-25A9E04E-900B-4780-BB9C-A15023B00FB1
p:P1552 wd:statement/Q412765-3557A320-AF5C-49F8-B30E-BAFE1930F4A3
p:P2062 wd:statement/Q412765-29D5F1F7-CDEB-4E01-B57E-5E5E5E78846B
p:P2115 wd:statement/Q412765-1AEB8F6B-6BEC-4074-ACD7-6EEA7BFB5009
p:P2175 wd:statement/Q412765-0E8E8512-D6AF-4BA5-8AAB-885EEED002A8
wd:statement/Q412765-A317A5CF-A702-47D8-B871-05E08B3165BD
wd:statement/Q412765-E02C28BA-B9FB-45A6-B0D3-095347BCD4A6
wd:statement/Q412765-FAD8658A-7E5C-4986-8BC9-0B438B037757
p:P2275 wd:statement/Q412765-06155805-D7F9-40E9-9419-A7D7B3AB5E80
p:P231 wd:statement/Q412765-9078A7DC-7DF9-4CDD-AB85-820A4D5268F4
p:P267 wd:statement/Q412765-5643D8CF-E557-4BBD-A2A8-B6A303BAD23C
p:P279 wd:statement/Q412765-2218F826-89FE-43F0-BF06-2FDB172F3738
p:P2868 wd:statement/Q412765-7442AF7E-FE7F-4CF8-AE31-DE437B6FF08F
wd:statement/Q412765-C8BC033B-8D20-49BB-9424-DD71A886E75E
p:P31 wd:statement/Q412765-615B61FB-7D8B-4813-8458-FD368AB70DF1
p:P3345 wd:statement/Q412765-F2A75C2A-453C-447A-BDC1-AA3BC88684DB
p:P366 wd:statement/Q412765-9DB708FB-7E55-4D51-9C15-B627D1D2E1CB
p:P3780 wd:statement/Q412765-F0FE377A-F800-470C-BEA2-208F985D6A5C
p:P4527 wd:statement/Q412765-E4D84E90-F300-4F3A-AEAB-EC60D3F5688D
p:P486 wd:statement/Q412765-C521500F-6BCA-47E3-B4A8-4F6EF13A1D11
p:P592 wd:statement/Q412765-67B7DA61-D6B5-4CE9-8BF4-6972154CBE66
p:P6366 wd:statement/Q412765-6B16A3A4-1867-4349-B267-AEA8F2B34620
p:P646 wd:statement/Q412765-0E2F4D7A-EB9F-4FBF-A9ED-0B9BA8B82787
p:P652 wd:statement/Q412765-B4EA9C9A-113F-4B1C-9727-300F80DBD5EC
p:P672 wd:statement/Q412765-00095ea4-4ce9-a2fd-efec-876a6bb1d5ab
wd:statement/Q412765-4b805f1a-4bc1-eaf2-1581-16a08ba31002
wd:statement/Q412765-7b6f8459-40de-18bf-a685-f056ed2ee319
p:P715 wd:statement/Q412765-4BE3810A-4329-4A3F-8672-5765C66BFA66
p:P9272 wd:statement/Q412765-036DE8E2-D764-42BE-A683-23D9455C3DCF
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148570>
p:direct-normalized/P4527 <http://data.parliament.uk/terms/428922>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/D000069455>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201586>
p:direct-normalized/P6366 <https://makg.org/entity/2778644256>
p:direct-normalized/P672 <http://id.nlm.nih.gov/mesh/D12.776.124.486.485.114.224.060.860>
<http://id.nlm.nih.gov/mesh/D12.776.124.790.651.114.224.060.860>
<http://id.nlm.nih.gov/mesh/D12.776.377.715.548.114.224.200.860>
wdt:P10245 "a698034"
wdt:P10283 "C2778644256"
wdt:P11143 "Palivizumab"
wdt:P1552 biopharmaceutical
wdt:P2062 "8178"
wdt:P2115 "N0000148570"
wdt:P2175 respiratory syncytial virus infectious disease
heart disease
lung disease
bronchopulmonary dysplasia
wdt:P2275 "palivizumab"@en
wdt:P231 "188039-54-5"
wdt:P267 "J06BB16"
wdt:P279 chemical compound
wdt:P2868 antiviral agent
monoclonal antibody
wdt:P31 type of chemical entity
wdt:P3345 "194279"
wdt:P366 medication
wdt:P3780 Synagis
wdt:P4527 "428922"
wdt:P486 "D000069455"
wdt:P592 "CHEMBL1201586"
wdt:P6366 "2778644256"
wdt:P646 "/m/0gdn5s"
wdt:P652 "DQ448MW7KS"
wdt:P672 "D12.776.124.486.485.114.224.060.860"
"D12.776.124.790.651.114.224.060.860"
"D12.776.377.715.548.114.224.200.860"
wdt:P715 "DB00110"
wdt:P9272 "55978"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata